BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

LaVoie Strategic Communications Group, Inc. Adds Transport Pharmaceuticals To Its Life Science Roster


8/21/2006 10:15:23 AM

SALEM, Mass., Aug. 21 /PRNewswire/ -- LaVoie Strategic Communications Group, Inc. (LaVoie Group), a life sciences focused public and investor relations firm, announced today that it has been selected by privately-held Transport Pharmaceuticals, Inc. of Framingham, MA as agency of record.

"LaVoie Group is focused on providing senior level strategic counsel and superior tactical execution to our growing roster of global life science clients. Transport Pharmaceuticals is a drug/device company focused in dermal diseases with core competencies in engineering, chemistry, and biology and drug development. We look forward to working and growing with Transport's management team as they progress into their next phase of clinical development," said Donna L. LaVoie, President and CEO, LaVoie Group.

About LaVoie Group

LaVoie Group provides senior level strategic counsel and tactical implementation of public, investor and corporate communications programs designed to properly position and create visibility that drives value for our clients. Our public and private clients range from start-ups to industry leaders, in multiple international markets.

About Transport Pharmaceuticals, Inc.

Transport Pharmaceuticals, Inc., is a privately-held company developing and designing drug/device combination products for the treatment of multiple dermatological diseases. The Company's lead product, SoloVir(TM), utilizes a proprietary drug formulation and an electrokinetic delivery-device to create a revolutionary paradigm shift in patient initiated treatment of herpes labialis, or cold sores.

Contact Donna L. LaVoie President & CEO LaVoie Group dlavoie@lavoiegroup.com 978-745-4200 X103 http://www.lavoiegroup.com

LaVoie Strategic Communications Group, Inc.

CONTACT: Donna L. LaVoie, President & CEO of LaVoie Group,+1-978-745-4200, ext. 103, dlavoie@lavoiegroup.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES